Mary Poor is a Director of Regulatory and Strategic Development - CMC at Clinipace Worldwide. In this position, she provides comprehensive quality systems and compliance support to clients at all phases of the pharmaceutical development process, including quality systems review and remediation, regulatory inspection preparation, and inspection support. Prior to joining Clinipace, she held positions in research, quality assurance management, and regulatory compliance. She has broad experience in the biotechnology industry, including contract manufacturing, quality systems design and implementation, supplier management, aseptic processing, development and provision of GxP training, and validation. Ms. Poor holds an M.S. in Microbiology from Colorado State University and has held professional certification in U.S. Regulatory Affairs from the Regulatory Affairs Professionals Society. She currently serves as member of the ISPE Rocky Mountain Chapter Board of Directors.